Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04373434 · ClinicalTrials.gov registry record · NA
Healthy Homes/Healthy Families (HH/HF) Intervention in 2-1-1 Callers
A NA study of Weight Change, Body, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 512
- Enrollment target
- 1
- Study location
NCT04373434: Completed NA study of Weight Change, Body, sponsored by Emory University.
NCT04373434 is a NA study of Weight Change, Body that has completed, run by Emory University. The registered enrollment target is 512 participants, below the 25,248-participant average among 4 other Weight Change, Body trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04373434, a NA study of Weight Change, Body, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will evaluate a healthy eating and weight gain prevention intervention for delivery through calls to the 2-1-1 number.
Primary Outcome
Description: The USDA HEI measures diet quality and is calculated from two telephone administered 24-hr dietary recalls (one weekday, one weekend day). The HEI evaluates foods with a scoring system using 13 components for different food groups and the key recommendations of the 2015-2020 "Dietary Guidelines for Americans." Scores range from 0 to 100 where a score of 100 is an ideal score indicating that a diet follows the key recommendations of the 2015-2020 "Dietary Guidelines for Americans" (h
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Health Homes/Healthy Families (HH/HF) Intervention
Study Locations (1)
Georgia
- Emory University, Rollins School of Public Health - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2023-08-28 |
| Phase | NA |
What the finished NCT04373434 record still lists
NCT04373434 is an interventional study that assigns participants to a tested intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap, below the 25,248-participant average among 4 other Weight Change, Body trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Weight Change, Body appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT04373434 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04373434 about?
NCT04373434 is a clinical study titled "Healthy Homes/Healthy Families (HH/HF) Intervention in 2-1-1 Callers". This trial will evaluate a healthy eating and weight gain prevention intervention for delivery through calls to the 2-1-1 number.
What is the current status of trial NCT04373434?
This trial is currently completed. It is a NA study. The enrollment target is 512 participants. The study started on 2020-09-18. Estimated completion is 2023-08-28.
What conditions does trial NCT04373434 study?
This clinical trial studies the following conditions: Weight Change, Body.
What interventions are being tested in trial NCT04373434?
The interventions under investigation include: Control (BEHAVIORAL), Health Homes/Healthy Families (HH/HF) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04373434?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04373434 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Change, Body
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
ACTIVE NOT RECRUITING · NA
-
Study of an International Commercial Program on Weight Loss and Health Outcomes
COMPLETED · NA
-
Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions
COMPLETED · NA
-
POWERMOM, A Healthy Pregnancy Research Community
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI